Bristol Myers Squibb Preferred Securities out of Shareholders Equity (Quarterly) Analysis

Bristol Myers Squibb Co. (BMY)

61.60 +0.35 (+0.57%) USD | NYSE | Feb 24, 16:00

61.30 -0.30 (-0.49%) Pre-Market: 06:23

View Preferred Securities out of Shareholders Equity (Quarterly) for BMY.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Preferred Securities out of Shareholders Equity (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Preferred Securities out of Shareholders Equity (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Preferred Securities out of Shareholders Equity (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	--
Gilead Sciences, Inc.	--
Regeneron Pharmaceuticals, Inc.	--
Janux Therapeutics, Inc.	--
Moderna, Inc.	--